Immunogenomics
Pharmacogenetics
Genomic medicine
B.S. National Taiwan University
M.S. National Cheng Kung University
Ph.D. National Taiwan University
Postdoc. Academia Sinica
Postdoc. University of Chicago, Chicago, IL
Our research interests are in applying advanced genomic platform to find the solution for improving the population health. We currently aim at translating the promise of high-throughput genomic medicine into clinical reality. We mainly apply single-cell multi-omics approaches and the developing technologies for analyzing highly polymorphic gene (i.e. HLA, TCR, KIR). In addition, our lab also has early access to the newest single-cell multi-omics technologies (scRNA-seq, scATAC-seq, scDNA-seq, CITE-seq, scVDJ-seq, spatial profiling, and other advanced single-cell platforms). Based on these platforms, we currently focus on leveraging single-cell analysis for translational studies in immune-mediated diseases and immunotherapies.
2012, Regular Postdoctoral Fellowship, Academia Sinica, Taiwan
2012, 1st Place of Oral Presentation Award, Thesis Award of Tsung-Ming Tu, Taiwan
2012, The poster price winners of the Drug Hypersensitivity Meeting 5, Germany
2012, FOCIS Travel Award of Federation of Clinical Immunology Societies, Canada
2012,2014,2016, Travel award given by the Foundation for the Advancement of Outstanding Scholarship
2013, Excellent Thesis Award from National Taiwan University, Taiwan
2014, Distinguished Postdoctoral Scholarship, Academia Sinica, Taiwan
2018, Tsung-Ming Tu’s YOUNG INVESTIGATOR AWARD, The Pharmacological Society in Taiwan, Taiwan
2018, YOUNG INVESTIGATOR AWARD, The 12th International Kawasaki Disease Symposium, Japan
2018, BioICT(Information and Communications Technology) Junior Chair Professor, National Chiao Tung University, Taiwan
2019, JCA-CHAAO Award (Category: Cancer research using artificial intelligence technologies on the frontiers of medical science), Japan